Page last updated: 2024-08-21

arsenic trioxide and Benign Intracranial Hypertension

arsenic trioxide has been researched along with Benign Intracranial Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feusner, JH; Gregory, J; Kutny, MA1
Fabry, U; Galm, O; Osieka, R1

Reviews

1 review(s) available for arsenic trioxide and Benign Intracranial Hypertension

ArticleYear
Treatment of paediatric APL: how does the therapeutic approach differ from adults?
    Best practice & research. Clinical haematology, 2014, Volume: 27, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Age of Onset; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Blood Coagulation Disorders; Bone Marrow Examination; Cell Differentiation; Child; Child, Preschool; Heart Diseases; Humans; Infant; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm, Residual; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Oxides; Prognosis; Pseudotumor Cerebri; Randomized Controlled Trials as Topic; Remission Induction; Risk Factors; Salvage Therapy; Tretinoin

2014

Other Studies

1 other study(ies) available for arsenic trioxide and Benign Intracranial Hypertension

ArticleYear
Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
    Leukemia, 2000, Volume: 14, Issue:2

    Topics: Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Neoplasms; Diplopia; Female; Humans; Leukemia, Promyelocytic, Acute; Oxides; Papilledema; Pseudotumor Cerebri

2000